Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Takepron Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]

NCT02151786 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02151786
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02151786 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Takepron Intravenous 30 mg Specified Drug-use Survey [Hemostatic Effect/Rebleeding Rate]
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
January 31, 2007
Completion date
March 31, 2010
Enrollment
1,120 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastric ulcer, duodenal ulcer, acute stress gastritis, and acute gastric mucosal lesions